Hepatitis C Treatment: Study Finds No Liver, Kidney or Cardiovascular Adverse Effects – Interview with: Elizabeth A. McGlynn, PhD Vice President for Kaiser Permanente Research Executive Director Kaiser Permanente Center for Effectiveness and Safety — No Comments

Leave a Reply

Your email address will not be published. Required fields are marked *